The New York Stock Exchange ended the session with Walmart slightly jumping 0.25% to $151.31 on Tuesday while the New York Stock Exchange rose 1.79% to $14,249.50.
Walmart’s yesterday’s close was $150.93, below its 52-week high of $153.40.
Walmart’s sales growth is 4.3% for the present quarter and 0.3% for the next. The company’s growth estimates for the present quarter and the next is 8% and 10.2%, respectively.
Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 548.74B for the twelve trailing months.
Walmart’s stock is valued at $151.31 at 19:59 EST, below its 52-week high of $153.40 and way above its 52-week low of $102.00.
Walmart’s value is higher than its 50-day moving average of $144.66 and way higher than its 200-day moving average of $133.41.
Walmart heirs back startup developing $10 at-home covid-19 tests. According to The Wall Street Journal on Sat Nov 21, “The billionaire Walton family that controls the retail giant is among a group of investors in NowDiagnostics, a startup aiming to design at-home coronavirus tests to sell for as little as $10 in Walmart stores and elsewhere..”
Walmart rejected by supreme court on texas liquor sales. According to Bloomberg Quint on Mon Nov 23, “Walmart Rejected by Supreme Court in Bid to Sell Liquor in Texas.”